WO2025056973 - COMPOSITIONS AND METHODS FOR MODULATING WISP2 SUPER-ENHANCER-ASSOCIATED RNA
National phase entry:
Publication Number
WO/2025/056973
Publication Date
20.03.2025
International Application No.
PCT/IB2024/000507
International Filing Date
13.09.2024
Title **
[English]
COMPOSITIONS AND METHODS FOR MODULATING WISP2 SUPER-ENHANCER-ASSOCIATED RNA
[French]
COMPOSITIONS ET PROCÉDÉS DE MODULATION D'ARN ASSOCIÉ À UN SUPER-ACTIVATEUR WISP2
Applicants **
HAYA THERAPEUTICS SA
Inventors
OUNZAIN, Samir
BLESSING, Daniel, Roman
MINA, Marco
MICHELETTI, Rudi
FERNANDEZ, Maria, Marcuello
CORELLA, Joaquim, Cruz
KARRAS, James, G.
Priority Data
63/538,198
13.09.2023
US
63/597,821
10.11.2023
US
63/559,107
28.02.2024
US
63/655,557
03.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4329 | |
| EPO | Filing, Examination, Granting | 25891 | |
| Japan | Filing, Examination, Granting | 2892 | |
| South Korea | Filing, Examination, Granting | 3677 | |
| USA | Filing, Examination, Granting | 12890 |
Total:
49,679
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are modulators of a long noncoding transcript, wherein expression of the long- noncoding transcript is associated with initiation, development, or prognosis of cardiac fibrosis.[French]
L'invention concerne des modulateurs d'un transcrit long non codant, l'expression du transcrit long non codant étant associée à l'initiation, au développement ou au pronostic de la fibrose cardiaque.